Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Single cell transcriptomics of mouse kidney transplants reveals a myeloid cell pathway for transplant rejection
Anil Dangi, Naveen R. Natesh, Irma Husain, Zhicheng Ji, Laura Barisoni, Jean Kwun, Xiling Shen, Edward B. Thorp, Xunrong Luo
Anil Dangi, Naveen R. Natesh, Irma Husain, Zhicheng Ji, Laura Barisoni, Jean Kwun, Xiling Shen, Edward B. Thorp, Xunrong Luo
View: Text | PDF
Research Article Immunology Transplantation

Single cell transcriptomics of mouse kidney transplants reveals a myeloid cell pathway for transplant rejection

  • Text
  • PDF
Abstract

Myeloid cells are increasingly recognized as major players in transplant rejection. Here, we used a murine kidney transplantation model and single cell transcriptomics to dissect the contribution of myeloid cell subsets and their potential signaling pathways to kidney transplant rejection. Using a variety of bioinformatic techniques, including machine learning, we demonstrate that kidney allograft–infiltrating myeloid cells followed a trajectory of differentiation from monocytes to proinflammatory macrophages, and they exhibited distinct interactions with kidney allograft parenchymal cells. While this process correlated with a unique pattern of myeloid cell transcripts, a top gene identified was Axl, a member of the receptor tyrosine kinase family Tyro3/Axl/Mertk (TAM). Using kidney transplant recipients with Axl gene deficiency, we further demonstrate that Axl augmented intragraft differentiation of proinflammatory macrophages, likely via its effect on the transcription factor Cebpb. This, in turn, promoted intragraft recruitment, differentiation, and proliferation of donor-specific T cells, and it enhanced early allograft inflammation evidenced by histology. We conclude that myeloid cell Axl expression identified by single cell transcriptomics of kidney allografts in our study plays a major role in promoting intragraft myeloid cell and T cell differentiation, and it presents a potentially novel therapeutic target for controlling kidney allograft rejection and improving kidney allograft survival.

Authors

Anil Dangi, Naveen R. Natesh, Irma Husain, Zhicheng Ji, Laura Barisoni, Jean Kwun, Xiling Shen, Edward B. Thorp, Xunrong Luo

×

Figure 5

Axl is differentially expressed by graft-infiltrating macrophages in rejecting versus tolerized kidney allografts.

Options: View larger image (or click on image) Download as PowerPoint

Axl is differentially expressed by graft-infiltrating macrophages in re...
(A) Expression of Axl as a function of pseudotime by myeloid cell clusters from the indicated groups. (B) Violin plot demonstrating that Axl is predominantly expressed by 3 myeloid cell clusters (Macro/Mono, Macro-1 and Macro-2) only. (C) CD45.2+ BALB/c kidneys were transplanted into congenic CD45.1+ WT B6 recipients. Recipients were either treated with donor ECDI-SP (tolerized) or not (rejecting). Kidney allografts were retrieved on d15 after transplantation for FACS analysis. Representative FACS plots showing intragraft CD45.1+ recipient–derived (majority) and CD45.2+ donor–derived (minimal) myeloid cells (left panels, cells were gated on total live CD11b+ myeloid cells, representative of n = 2 in each group). CD45.1+ recipient myeloid cells were further analyzed for their expression of Axl and F4/80 (right panels, representative of n = 2 in each group). (D) Left: total numbers of Axl+F4/80+ macrophages per kidney allograft as shown in C. Right: MFI of Axl expression normalized to the isotype control.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts